4-amino-2-(1H-imidazol-2-yl)-7-[(6-methyl-3-pyridinyl)methyl]-5H-pyrrolo[2,3-d]pyrimidin-6-one;8-ethoxy-9-[(6-methyl-3-pyridinyl)methyl]-2-[1-(2-trimethylsilylethoxymethyl)imidazol-2-yl]purin-6-amine;methane;tungsten
C40H51N15O3SiW — CID 161117806
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-amino-2-(1H-imidazol-2-yl)-7-[(6-methyl-3-pyridinyl)methyl]-5H-pyrrolo[2,3-d]pyrimidin-6-one;8-ethoxy-9-[(6-methyl-3-pyridinyl)methyl]-2-[1-(2-trimethylsilylethoxymethyl)imidazol-2-yl]purin-6-amine;methane;tungsten
4-amino-2-(1H-imidazol-2-yl)-7-[(6-methyl-3-pyridinyl)methyl]-5H-pyrrolo[2,3-d]pyrimidin-6-one;8-ethoxy-9-[(6-methyl-3-pyridinyl)methyl]-2-[1-(2-trimethylsilylethoxymethyl)imidazol-2-yl]purin-6-amine;methane;tungsten (PubChem CID 161117806) has the molecular formula C40H51N15O3SiW and a molecular weight of 1001.88 g/mol. Its IUPAC name is 4-amino-2-(1H-imidazol-2-yl)-7-[(6-methyl-3-pyridinyl)methyl]-5H-pyrrolo[2,3-d]pyrimidin-6-one;8-ethoxy-9-[(6-methyl-3-pyridinyl)methyl]-2-[1-(2-trimethylsilylethoxymethyl)imidazol-2-yl]purin-6-amine;methane;tungsten.
Molecular Properties
| Compound Name | 4-amino-2-(1H-imidazol-2-yl)-7-[(6-methyl-3-pyridinyl)methyl]-5H-pyrrolo[2,3-d]pyrimidin-6-one;8-ethoxy-9-[(6-methyl-3-pyridinyl)methyl]-2-[1-(2-trimethylsilylethoxymethyl)imidazol-2-yl]purin-6-amine;methane;tungsten |
|---|---|
| PubChem CID | 161117806 |
| Molecular Formula | C40H51N15O3SiW |
| Molecular Weight | 1001.88 g/mol |
| Exact Mass | 1001.36 |
| IUPAC Name | 4-amino-2-(1H-imidazol-2-yl)-7-[(6-methyl-3-pyridinyl)methyl]-5H-pyrrolo[2,3-d]pyrimidin-6-one;8-ethoxy-9-[(6-methyl-3-pyridinyl)methyl]-2-[1-(2-trimethylsilylethoxymethyl)imidazol-2-yl]purin-6-amine;methane;tungsten |
| SMILES | C.CCOc1nc2c(N)nc(-c3nccn3COCC[Si](C)(C)C)nc2n1Cc1ccc(C)nc1.Cc1ccc(CN2C(=O)Cc3c(N)nc(-c4ncc[nH]4)nc32)cn1.[W] |
| InChI | InChI=1S/C23H32N8O2Si.C16H15N7O.CH4.W/c1-6-33-23-27-18-19(24)28-20(22-25-9-10-30(22)15-32-11-12-34(3,4)5)29-21(18)31(23)14-17-8-7-16(2)26-13-17;1-9-2-3-10(7-20-9)8-23-12(24)6-11-13(17)21-15(22-16(11)23)14-18-4-5-19-14;;/h7-10,13H,6,11-12,14-15H2,1-5H3,(H2,24,28,29);2-5,7H,6,8H2,1H3,(H,18,19)(H2,17,21,22);1H4; |
| InChIKey | VPXGIRAIQMLIDB-UHFFFAOYSA-N |
| XLogP | 5.61 |
| TPSA | 232.47 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 16 |
| Rotatable Bonds | 13 |
| Heavy Atoms | 60 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1001.88 |
| LogP ≤ 5 | 5.61 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 16 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 161117806 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.